These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27128435)

  • 41. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study.
    Clemente C; Elba S; Buongiorno G; Guerra V; D'Attoma B; Orlando A; Russo F
    Liver Int; 2007 Aug; 27(6):791-7. PubMed ID: 17617122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis.
    Aleman S; Rahbin N; Weiland O; Davidsdottir L; Hedenstierna M; Rose N; Verbaan H; Stål P; Carlsson T; Norrgren H; Ekbom A; Granath F; Hultcrantz R
    Clin Infect Dis; 2013 Jul; 57(2):230-6. PubMed ID: 23616492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers.
    Suh B; Park S; Shin DW; Yun JM; Yang HK; Yu SJ; Shin CI; Kim JS; Ahn E; Lee H; Park JH; Cho B
    Hepatology; 2015 Apr; 61(4):1261-8. PubMed ID: 25502481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Ohata K; Hamasaki K; Toriyama K; Ishikawa H; Nakao K; Eguchi K
    J Gastroenterol Hepatol; 2004 Jun; 19(6):670-5. PubMed ID: 15151623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lower incidence of hepatic failure than hepatocellular carcinoma in Japanese patients with chronic hepatitis C.
    Imazeki F; Yokosuka O; Fukai K; Kawai S; Kanda T; Kojima H; Saisho H
    Liver Int; 2005 Aug; 25(4):772-8. PubMed ID: 15998428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Viral hepatitis and hepatocellular carcinoma.
    Marrero CR; Marrero JA
    Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy.
    Tokita H; Fukui H; Tanaka A; Kamitsukasa H; Yagura M; Harada H; Okamoto H
    J Gastroenterol Hepatol; 2005 May; 20(5):752-8. PubMed ID: 15853990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
    Nair S; Mason A; Eason J; Loss G; Perrillo RP
    Hepatology; 2002 Jul; 36(1):150-5. PubMed ID: 12085359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
    Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
    J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Velázquez RF; Rodríguez M; Navascués CA; Linares A; Pérez R; Sotorríos NG; Martínez I; Rodrigo L
    Hepatology; 2003 Mar; 37(3):520-7. PubMed ID: 12601348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients.
    Arano T; Nakagawa H; Tateishi R; Ikeda H; Uchino K; Enooku K; Goto E; Masuzaki R; Asaoka Y; Kondo Y; Goto T; Shiina S; Omata M; Yoshida H; Koike K
    Int J Cancer; 2011 Nov; 129(9):2226-35. PubMed ID: 21170963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endoscopic prediction of hepatocellular carcinoma by evaluation of bleeding esophageal varices.
    Nakayama H; Masuda H; Miyake H; Takayama T; Yokoyama E
    Digestion; 2004; 70(4):233-9. PubMed ID: 15627772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients.
    Sangiovanni A; Colombo E; Radaelli F; Bortoli A; Bovo G; Casiraghi MA; Ceriani R; Roffi L; Redaelli A; Rossini A; Spinzi G; Minoli G
    Am J Gastroenterol; 2001 May; 96(5):1575-80. PubMed ID: 11374702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hepatocellular carcinoma: rising incidence of hepatitis C virus-associated cases at a university clinic in Germany].
    Erhardt A; Theobald I; Petry W; Röhrborn A; Heintges T; Wettstein M; Häussinger D
    Dtsch Med Wochenschr; 2002 Dec; 127(50):2665-8. PubMed ID: 12481236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis.
    Nkontchou G; Ziol M; Aout M; Lhabadie M; Baazia Y; Mahmoudi A; Roulot D; Ganne-Carrie N; Grando-Lemaire V; Trinchet JC; Gordien E; Vicaut E; Baghad I; Beaugrand M
    J Viral Hepat; 2011 Oct; 18(10):e516-22. PubMed ID: 21914071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression and cellular localization of fibrillin-1 in normal and pathological human liver.
    Dubuisson L; Lepreux S; Bioulac-Sage P; Balabaud C; Costa AM; Rosenbaum J; Desmoulière A
    J Hepatol; 2001 Apr; 34(4):514-22. PubMed ID: 11394650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.